Akili, Inc. (AKLI)
Jul 2, 2024 - AKLI was delisted (reason: acquired by Virtual Therapeutics)
0.433
+0.001 (0.25%)
Inactive · Last trade price on Jul 1, 2024

Akili Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
Current Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
343887317-
Market Cap Growth
-81.81%-56.29%-72.44%--
Enterprise Value
-16-22-29246-15
PE Ratio
--0.64-4.58-2.50-
PS Ratio
17.5022.73270.15588.60-
PB Ratio
0.680.650.79-1.40-
P/FCF Ratio
-0.46-0.66-1.04-5.81-
P/OCF Ratio
-0.47-0.66-1.04-5.87-
EV/Sales Ratio
-13.87-13.01-90.45457.04-3.93
EV/EBITDA Ratio
0.600.395.16-4.060.62
EV/EBIT Ratio
0.580.384.52-4.040.61
EV/FCF Ratio
0.550.380.35-4.510.63
Debt / Equity Ratio
0.270.260.18-0.03-0.03
Debt / EBITDA Ratio
-0.30-0.28-3.52-0.11-0.14
Debt / FCF Ratio
-0.28-0.27-0.24-0.12-0.14
Quick Ratio
5.665.8410.039.604.81
Current Ratio
5.806.0210.379.924.88
Asset Turnover
0.020.020.000.01-
Interest Coverage
-21.15-24.21-4.35-130.93-76.01
Return on Equity (ROE)
-74.50%-78.50%26.20%218.00%-
Return on Assets (ROA)
-55.10%-58.10%-17.80%-152.10%-
Return on Capital (ROIC)
-88.13%-87.12%-69.41%27.64%25.06%
Earnings Yield
-142.38%-155.97%-21.82%-40.00%-
FCF Yield
-144.11%-152.08%-95.77%-17.20%-
Buyback Yield / Dilution
-0.57%-161.72%-2067.39%-19.32%-
Total Shareholder Return
-0.57%-161.72%-2067.39%-19.32%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).